Publications by authors named "David F Callen"

Claim this Profile
T
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer.
Alaknanda Adwal, Priyakshi Kalita-de Croft, Reshma Shakya, Malcolm Lim, Emarene Kalaw, David F Callen

Life Sci Alliance· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammary-specific ablation of Cyp24a1 inhibits development, reduces proliferation and increases sensitivity to vitamin D.
Lei Sheng, Andrew G Turner, Kate Barratt, Richard Kremer, Howard A Morris, David F Callen

J Steroid Biochem Mol Biol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
Yoon-Sim Yap, Prabhakaran Munusamy, Cindy Lim, Claire H T Chan, Aldo Prawira, David F Callen

Breast Cancer Res Treat· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response.
Kathleen I Pishas, Christina D Drenberg, Cenny Taslim, Emily R Theisen, Kirsten M Johnson, David F Callen

Mol Cancer Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
Kejia Hu, David Frederick Callen, Jiayuan Li, Hong Zheng

Integr Cancer Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D signaling and breast cancer: Insights from transgenic mouse models.
Lei Sheng, David F Callen, Andrew G Turner

J Steroid Biochem Mol Biol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naturally existing isoforms of miR-222 have distinct functions.
Feng Yu, Katherine A Pillman, Corine T Neilsen, John Toubia, David M Lawrence, David F Callen

Nucleic Acids Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azobenzene-containing photoswitchable proteasome inhibitors with selective activity and cellular toxicity.
Beatriz Blanco, Kathryn A Palasis, Alaknanda Adwal, David F Callen, Andrew D Abell

Bioorg Med Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4.
Qingqing Wang, Luke A Selth, David F Callen

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Detection in Human Tissue Samples Using a Fiber-Tip pH Probe.
Erik P Schartner, Matthew R Henderson, Malcolm Purdey, Deepak Dhatrak, Tanya M Monro, David F Callen

Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Peptidomimetic Boronates for Selective Inhibition of the Chymotrypsin-like Activity of the 26S Proteasome.
Xiaozhou Zhang, Alaknanda Adwal, Andrew G Turner, David F Callen, Andrew D Abell

ACS Med Chem Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of vitamin D target genes in human breast cancer tissue.
Lei Sheng, Paul H Anderson, Andrew G Turner, Kathleen I Pishas, Deepak J Dhatrak, David F Callen

J Steroid Biochem Mol Biol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA.
Feng Yu, Cameron P Bracken, Katherine A Pillman, David M Lawrence, Gregory J Goodall, David F Callen

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: XI-006 induces potent p53-independent apoptosis in Ewing sarcoma.
Kathleen I Pishas, Alaknanda Adwal, Susan J Neuhaus, Mark T Clayer, Gelareh Farshid, David F Callen

Sci Rep· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XI-006 induces potent p53-independent apoptosis in Ewing sarcoma.
Kathleen I Pishas, Alaknanda Adwal, Susan J Neuhaus, Mark T Clayer, Gelareh Farshid, David F Callen

Sci Rep· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of ANKRD11 mutations in humans and mice related to KBG syndrome.
Katherina Walz, Devon Cohen, Paul M Neilsen, Joseph Foster, Francesco Brancati, David F Callen

Hum Genet· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ankrd11 is a chromatin regulator involved in autism that is essential for neural development.
Denis Gallagher, Anastassia Voronova, Mark A Zander, Gonzalo I Cancino, Alexa Bramall, David F Callen

Dev Cell· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NF1 gene revisited - from bench to bedside.
Yoon-Sim Yap, John R McPherson, Choon-Kiat Ong, Steven G Rozen, Bin-Tean Teh, David F Callen

Oncotarget· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication.
Pegah Johansson, Jessie Jeffery, Fares Al-Ejeh, Renèe B Schulz, David F Callen

J Biol Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling.
Kathleen I Pishas, Susan J Neuhaus, Mark T Clayer, Andreas W Schreiber, David M Lawrence, David F Callen

Cancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A template-based approach to inhibitors of calpain 2, 20S proteasome, and HIV-1 protease.
Seth A Jones, Paul M Neilsen, Limei Siew, David F Callen, Nathan E Goldfarb

ChemMedChem· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth.
Sam Mattiske, Kristen Ho, Jacqueline E Noll, Paul M Neilsen, David F Callen

Oncotarget· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-activation of the p53 pathway through Nutlin-3a sensitises sarcomas to drozitumab therapy.
Kathleen I Pishas, Susan J Neuhaus, Mark T Clayer, Alaknanda Adwal, Michael P Brown, David F Callen

Oncol Rep· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors.
Ashok D Pehere, Markus Pietsch, Michael Gütschow, Paul M Neilsen, Daniel Sejer Pedersen, David F Callen

Chemistry· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabine.
Sue Ping Lim, Raman Kumar, Yamini Akkamsetty, Wen Wang, Kristen Ho, David F Callen

BMC Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis